Konstantinos Laios

Konstantinos Laios

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Toxicology Reports
Verified
Journal Article
Open access
SMSpyros N. Michaleas
Spyros N. Michaleas
KLKonstantinos Laios
Konstantinos Laios
GTGregory Tsoucalas
Gregory Tsoucalas
GAGeorges Androutsos
Georges Androutsos
• Paracelsus introduced the use of chemical substances, such as minerals, into medicine. • Paracelsus theorized the constitution of matter based on three elements: sulphur, salt and mercury. • Paracelsus emphasized the importance of dosing in distinguishing between toxicity and treatment.

Verified
Journal Article
Open access
PDF file
MSMaria Chantal Simon
Maria Chantal Simon
KLKonstantinos Laios
Konstantinos Laios
INIoannis Nikolakakis
Ioannis Nikolakakis
Theodore G. PapaioannouTheodore G. Papaioannou
Theodore G. Papaioannou
Background/Objectives: The present investigation evaluates the impact of 3D-printing technology on the design of pharmaceutical drugs, considering the feasibility issues and problems concerning technological, pharmaceutical, and clinical matters. This paper aims to review how 3D printing can modify the traditional manufacturing of drugs with personalized medicine-therapy outcomes being individualized and optimized, hence improving patients’ compliance. Methods: The historical development of 3D printing from rapid prototyping to advanced pharmaceutical applications is discussed. A comparison is then made between traditional drug manufacturing approaches and the different techniques of 3D printing, including stereolithography, material extrusion, and binder jetting. Feasibility is assessed based on clinical trials and studies evaluating the efficacy, safety, bioavailability, and cost-effectiveness of 3D-printed drugs. Results: Current evidence indicates that material selection, regulatory barriers, and scalability issues are some of the major challenges to be overcome for wider acceptance. Other matters, such as ethical issues concerning patient data privacy, the misuse of 3D-printing technology, and technical complexities related to pharmaceutical 3D printing, are discussed further. Future applications also include bioprinting and in situ printing together with their implications for personalized drug delivery, which will also be discussed. Conclusions: This review stresses that intersectoral collaboration and the updating of regulatory frameworks are a must to overcome the barriers that confront 3D-printing applications in drug development. can could be an opportunity for innovative licensing and manufacturing techniques in pharmaceutical product development that can change the paradigm of personalized medicine through modern printing techniques.

21 December 2022 in Cureus
Verified
Journal Article
Open access
SMSpyros N. Michaleas
Spyros N. Michaleas
KLKonstantinos Laios
Konstantinos Laios
ACAlexandros Charalabopoulos
Alexandros Charalabopoulos
GSGeorge Samonis
George Samonis
MKMarianna Karamanou
Marianna Karamanou
Joseph Lister was a prominent British surgeon and medical scientist who established the study of antisepsis. Applying Louis Pasteur’s germ theory of fermentation on wound putrefaction, he promoted the idea of sterilization in surgery using carbolic acid (phenol) as an antiseptic. His method reduced the incidence of wound sepsis and gangrene, which, in turn, reduced the need for amputation. By showing how germs could be prevented from entering the wound, Lister increased the safety of surgical operations and laid the foundations for all subsequent advances in the field.

27 March 2019 in Surgical Innovation
Verified
Journal Article
Closed access
PDF file
GTGregory Tsoucalas
Gregory Tsoucalas
KLKonstantinos Laios
Konstantinos Laios
GZGeorge Zografos
George Zografos
GAGeorges Androutsos
Georges Androutsos
MKMarianna Karamanou
Marianna Karamanou
Born in an island with huge medical tradition in ancient Greece, Praxagoras of Cos became an esteemed medico-philosopher and surgeon. The evolution made by the Hippocratic School of Medicine further boosted his talent and helped him perform surgical operations, which were believed impossible for his era. Praxagoras introduced an innovative surgical technique to confront small bowel obstruction, by creating an enterocutaneous fistula. This historical review connects all available data to present the life and work of an important medical figure of the ancient Hellenic School.

20 September 2019 in Surgical Innovation
Verified
Journal Article
Closed access
PDF file
KLKonstantinos Laios
Konstantinos Laios
VBVangelis Bontinis
Vangelis Bontinis
ABAlkis Bontinis
Alkis Bontinis
EMEvangelos Mavrommatis
Evangelos Mavrommatis
PLPavlos Lytsikas-Sarlis
Pavlos Lytsikas-Sarlis
GAGeorge Androutsos
George Androutsos
Mathieu Jaboulay (1860-1913) was an inventor in vascular and general surgery. He fabricated many new surgical techniques and instruments such as Jaboulay method for vascular sutures, Jaboulay anastomotic button, and Jaboulay amputation, known also as hemipelvectomy. In addition, he was a pioneer in heterologous transplantation and sympathectomy. He found death suddenly in a terrible train crash. He was a reputable Professor of Surgery at Lyon Faculty of Medicine with prestigious students in vascular surgery.

19 April 2018 in Hormones
Verified
Journal Article
Closed access
PDF file
KLKonstantinos Laios
Konstantinos Laios